跳至主要内容
临床试验/CTRI/2024/03/064161
CTRI/2024/03/064161尚未招募4 期

Comparative study to evaluate efficacy and safety of topical alcaftadine 0.25% versus topical olopatadine 0.2% eye drops in patients with allergic conjunctivits in a tertiary care teaching hospital, Haldwani - NI

eeraj Rajdan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient aged 5-20 years of age with history of allergic conjunctivitis presenting to OPD will be enrolled

排除标准

  • Subjects undergone any ocular surgical intervention within three months
  • Patients on steroid therapy, immunotherapeutic agents
  • Patients using other topical eye drops (ocular lubricants)
  • Patients used any investigational medication within one month of the study
  • Patients with known hypersensitivity to Olopatadine & Alcaftadine
  • Pregnant and lactating women

研究者

发起方
eeraj Rajdan

相似试验